hyperuricemia


Also found in: Dictionary, Medical, Wikipedia.
Related to hyperuricemia: purine, uric acid

hyperuricemia

[¦hī·pər‚yu̇r·ə′sē·mē·ə]
(medicine)
Abnormally high level of uric acid in the blood. Also known as lithemia.
References in periodicals archive ?
These high effluxes of metabolites result in abnormal accumulation in the blood and exceed the capacity of renal clearance and results hyperkalemia, hyperuricemia, hyperphosphatemia and secondary hypocalcemia.
In large amounts, however, too much uric acid can trigger hyperuricemia.
The semi-structured English-language questionnaire included the following parts: Demographic and professional information such as age, gender, specialty, years of practice, and average number of patients seen per day; perceptions about AH, including its definition, correlation with gout, and awareness about its major causes; knowledge about AH (subscales included pathophysiology, common etiological factors, and dietary recommendations for people with hyperuricemia); level of practice in AH management (subscales included history taking, physical examination, evaluation of comorbid conditions, complementary investigations, and treatment/ management of AH, including medication prescribing patterns); perceived barriers to the management of hyperuricemia.
There is now an indirect but proven link between hyperuricemia and cardiovascular disease as well as stroke', Prof.
He added that hyperuricemia can be managed even in patients on diuretic therapy (Arthritis Res Then 2018;20:53).
The parents or sister did not present hyperuricemia; however, the mother exhibited the same abnormality with an increased urine excretion of UA.
For inclusion, patients had to have hyperuricemia, defined as a serum uric acid level of 7.0 mg/dl, or higher, and they had to have experienced no more than two gout flares in the past year.
Based on an estimated prevalence of gout of 3.9% (8.3 million) and hyperuricemia (ie, serum uric acid [sUA] level >7.0 mg/dL in men and >5.7 mg/dL in women) of 21.4% (43.3 million) among US adults, approximately 1 in 5 people with hyperuricemia develop symptoms of gout.
Ironwood Pharmaceuticals is commercializing linaclotide for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), and lesinurad, which is approved to be taken with a xanthine oxidase inhibitor (XOI) for the treatment of hyperuricemia associated with uncontrolled gout.
Hyperuricemia is characterized by an elevated serum urate (>6-7 mg/dL) and has been found to be an increasing problem among Filipinos and elsewhere in the world.
Hyperuricemia is characterized by the excessive production of uric acid and is associated with metabolic syndrome, heart disease, endothelial dysfunction, and kidney injury.